Jesse Salk is the founder of TwinStrand Biosciences. TwinStrand Biosciences has raised $78M in total funding. Latest round: Series B.
Jesse Salk, MD PhD, is the co-founder of TwinStrand Biosciences, a Seattle-based gene-sequencing startup specializing in Duplex Sequencing technology. He previously served as the company's CEO before stepping down in 2022 and continues to be associated with the company as a founder.
Full founder directory · Investor directory · Company funding database · Fundraising library